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Rasthe activity of Saccharomyces cerevisiae Ras-GEF Cdc25 are still largely unknown.
While the catalytical function of the C-terminal domain has been thoroughly studied, only recently a role of
negative control on the protein activity has been suggested for the dispensable N-terminal domain. In order
to investigate Cdc25 localization and the role of its different domains, several fusion proteins were
constructed using the full length Cdc25 or different fragments of the protein with the green ﬂuorescent
protein. Unexpectedly, even if only slightly overexpressed, the full protein was not located in the cell plasma
membrane, but accumulates inside the cell and also into the nucleus. Moreover, the endogenous Cdc25,
tagged with HA, was also found in puriﬁed nuclear extracts. The fusions spanning aa 353–875, aa 876–1100
or aa 353–1100 localize heavily in the nucleus, concentrating in the nuclear peripheral area, in a region
distinct from the nucleolus. This could be related to the presence of two predicted nuclear localization signals
(NLS) in positions 547 and 806, but also to the contribution of another region, spanning residues 876–1100.
This localization is likely to be physiological, since the fusion proteins can be efﬁciently exported and then
imported back into the nucleus.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
In the yeast S. cerevisiae the Cdc25/Ras/cAMP pathway plays a role
in the regulation of cell growth and proliferation in response to the
availability of nutrients [1] and in the adaptation to glucose. The
increase in cytosolic cAMP levels activates the cAMP-dependent
protein kinase (pKA), which has an essential role in the progression
from the G1 to S phase of the cell cycle [2]. The Ras proteins are, in
addition, necessary for completing mitosis [3] and regulating
ﬁlamentous growth [4].
Due to their intrinsically slow GTPase and GTP/GDP exchange
activities, Ras proteins are strictly controlled by two classes of
regulatory proteins: GTPase activating proteins (GAPs) and guanine
nucleotide exchange factors (GEFs). In yeast, RasGAPs are represented
by Ira1 and Ira2 proteins, while RasGEFs are Cdc25 and Sdc25 [2].
While CDC25 is an essential gene in most genetic backgrounds [5],
SDC25 is dispensable and is normally expressed only during nutrient
depletion or on non-fermentable carbon sources [6]. Thus, the main
positive regulator of yeast Ras proteins is CDC25 gene product.
Cdc25 protein is a ~180 kDa polypeptide with a C-terminal highly
conserved Ras-GEF catalytic domain [7,8], which seems sufﬁcient for
full biological activity in yeast [9,10]. The large N-terminal portion
(residues 1–1121) contains an SH3 domain (residues 65–134),
involved in protein–protein interactions with adenylyl cyclase [11],
and a cyclin destruction box (CDB, position 149) which is important90264483565.
gani).
l rights reserved.for the short half-life of the protein [12]. Despite many studies on this
subject, some Cdc25 features remain obscure: although its catalytical
activity is required for the glucose-activation of adenylyl cyclase
[9,13–15], the N-terminal domain seems to be completely dispensable
for this response [16]. In addition there are some evidences that the
N-terminal region could have a negative regulatory role [17–19].
Cdc25 protein is tightly bound to a crude membrane fraction even
after treatment with reagents able to release membrane peripheral
proteins [4,8,20]. The mechanism of this membrane attachment is still
unclear, since Cdc25 does not contain a well deﬁned transmembrane
domain or a post-translational modiﬁcation responsible for mem-
brane attachment, and can be released from membranes only in
denaturing conditions [20]. It was proposed that the phosphorylation
of several Cdc25 residues within the 114–348 region could inﬂuence
this membrane attachment, making the protein more soluble when
hyperphosphorylated [17]; nevertheless, the most C-terminal of the
three highly conserved boxes in the catalytical domain (aa 1454–1475)
is hydrophobic and was included in the minimal region identiﬁed as
sufﬁcient for insolubility, spanning residues 1141–1552 [19]. Immuno-
ﬂuorescence against overexpressed Cdc25 showed a particulate
localization in distinct patches [10,19] both for the full-length protein,
for the catalytic fragment (residues 987–1589) or for the shortest
insoluble fragment (1441–1552). On the contrary, the 411 aa
N-terminal domain was reported as at least partially soluble but its
role in Cdc25 localization has never been further investigated.
In this work, Cdc25 localization in growing cells was studied using
protein fusionswith thegreenﬂuorescentprotein (eGFP).Unfortunately,
the level of endogenous protein expression makes it very hard to
Fig. 1. Cdc25 protein as an eGFP fusion reveals a nuclear and cytosolic localization. (A) Cells transformed whether with YICDC25eGFP (a), YEpCDC25eGFP (b) or YEpeGFPCDC25 (c)
were grown in SD-ura medium at 30 °C until exponential phase and then eGFP ﬂuorescence was photographed on living cells with a Nikon Eclipse E600 microscope. (B) Analysis of
living cells expressing YEpCDC25eGFP at the confocal microscope shows a punctuate pattern. Setting is described in Materials and methods. (a) Single optical section. (b) Image
generated by the average of a stack of 5 optical sections.
Fig. 2. Endogenous Cdc25 protein co-puriﬁes with nuclei. Nuclei were prepared from
exponentially growing cells of OL568-1C strain or from W303-1a strain carrying
YEpCDC25eGFP (for Cdc25eGFP) as described in Materials and methods and the
indicated proteins were revealed as internal membrane markers: Act1 (cytosolic and
cytoskeleton protein), Gas1 (plasma membrane, ER and Golgi), Anp1 (Golgi), Tom40
(mitochondrial membrane), Pho8 (vacuolar membranes), while Nop1was assayed as an
intact nuclei marker. Total extract (30 μg of proteins for HAx3::Cdc25, Cdc25eGFP, Ras2,
Pho8 and Nop1; 10 μg for Act1, Gas1, Anp1, Tom40) and the corresponding amount of
nuclei fraction (1/6th of the proteins loaded for total extract) were loaded on SDS-PAGE
and the indicated proteins were visualized by western blot.
2364 R. Tisi et al. / Biochimica et Biophysica Acta 1783 (2008) 2363–2374observe the localization as an eGFP fusion. However, when over-
expressed, the fusion protein accumulates in both the cytosol and the
nucleus, but not in the plasma membrane. The region responsible for
nuclear localizationwas identiﬁed as the central uncharacterized region
(residues 353–1100). In agreement, the endogenous Cdc25 (taggedwith
HA) was also found in puriﬁed nuclei. The effect of cell stress, nutrient
starvation or unbalanced PKA activity, on Cdc25 localization, was
investigated.
2. Materials and methods
2.1. Yeast strains and media
Plasmids were introduced in the W303-1a wild-type strain (Mata
ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1) by lithium/
acetate standard method. KT98 (a kind gift from K. Thorn, Harvard
University, USA), isogenic to W303-1a, expresses a fusion of Nup49
protein with the ﬂuorescent protein tdimer [22]. The haploid
OL568-1C strain (Matα ade2-1 his3-11 leu2-3,112 trp1-1 ura3-1
3xHA::CDC25) [23], kindly given by M. Jacquet (Université Paris-Sud,
Orsay Cedex, France), was used for nuclei preparation. The OL97-1-11B
strain (Mata cdc25-5 his3 his7 leu2 ura3) was used for complementa-
tion assay. W303 [YepTPK1] was previously described [15]. The
CDC25NES yeast strain (OL568-1C except for CDC25::3xHAcdc25NES::
Sphis5+) construction is described below.
YPDmedia contained 1% yeast extract and 2% peptone (Biolife) and
was supplemented with 2% glucose; synthetic complete media (SD)
contained 2% glucose, 6.7 g/l YNB (Difco) w/o aminoacids, and the
proper selective drop-out CSM (Complete Synthetic Medium, supplied
by BIO101, California, USA); synthetic media (SM) contained 2%
glucose, 6.7 g/l YNB (Difco) w/o aminoacids, and 50 mg/l of the
essential aminoacids and bases.
2.2. Plasmids
eGFP ORF was sub-cloned from pEGFP plasmid (Clontech) cutting
withEcoRI (ﬁlledwithKlenow fragment) andHindIII intoHindIII–EcoRV
digested pYX212 (Novagen), as a control for eGFP localization in yeast.CDC25-eGFP fusion was made by utilizing the SphI site in CDC25
ORF (position 4650) and the SphI site in the pEGFP plasmid. First, the
fusion was obtained in a N-terminal deletion construct, Yep13-CDC25
(907–1589), previously described [19], by sub-cloning the PvuII–SphI
fragment in PvuII–SphI digested pEGFP, obtaining pCAT-eGFP. Then,
the fusion was excised by cutting with PvuII and NotI (ﬁlled with
Klenow fragment), and inserted into the SmaI site of a multicopy
plasmid, YEplac195 [24], to generate YEp(907–1551)eGFP.
The 1–1551 aa fusion construct was realized by sub-cloning the
HindIII fragment from pCDC25(LEU2)-2 [25] in the HindIII cut pCAT-
eGFP, creating pCDC25eGFP. The multicopy plasmid pYX(1–1551)
eGFP, with the 1–1551 aa fusion protein expression driven by a strong
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strategy: ﬁrst, the HindIII fragment from Yep13-CDC25 was sub-
cloned in HindIII site of pYXeGFP, giving pYX(1–1501)eGFP; then, the
PvuII–StuI fragment from pCDC25eGFP was rearranged by homo-
logous recombination in yeast with the SalI digested pYX(1–1501)
eGFP, giving pYX(1–1551)eGFP.
An episomic construct, YEpCDC25eGFP, containing the 1–1551 aa
fusion ORF under CDC25 own promoter was obtained by homologous
recombination in yeast of the HindIII fragment from pCDC25(LEU2)-2
and the BglII digested YEp(907–1551)eGFP. An integrative vector, YI
CDC25eGFP, was obtained by ligating a ClaI digested un-methylated
preparation of the pYX(1–1551)eGFP plasmid.
pYX(1–1100)eGFPwas constructed by ligating the HindIII fragment
from pYX212-CDC25(1–1100) [19] in the HindIII site of pYXeGFP. pYX
(354–1100)eGFP and pYX(876–1100)eGFP were obtained by sub-
cloning the HindIII–PvuII fragment from pYX(1–1100)eGFP in the
HindIII–SmaI digested pYX212-CDC25(353–1100) or pYX212-CDC25
(876–1100) [19], respectively. pYX(353–875)eGFP and pYX(1–353)Fig. 3. Overexpression of Cdc25 N-terminal region sub-fragments identiﬁes two domains tha
representation of the constructs utilized to overexpress different eGFP fusions with the indic
transformed with pYX(1–1100)eGFP (a), pYX(353–1100)eGFP (b), pYX(876–1100)eGFP (c),
(494–685) (g) were grown in SD-ura medium at 30 °C until exponential phase and then eGeGFP were prepared by ligating respectively the 1600 bp BglII-
fragment or the 1400 bp BamHI–BglII fragment from pYX212-CDC25
(1–1100) in the BamHI digested pYX(1–1100)eGFP. pYX(770–875)
eGFP was obtained by EcoRI–EcoRI deletion in pYX(353–875)eGFP.
pYXeGFP(494–685) was prepared by ﬁrst deleting SacI–SacI fragment
from pYX212-CDC25(353–875), giving pYX212-CDC25(354–685),
then subcloning NcoI–SmaI 777 bp fragment from pEGFP-C1 (Clon-
tech) in NcoI–EcoRV of pYX212-CDC25(354–685). An eGFP dimer was
created by modifying by PCR the eGFP ORF from pEGFP-C1 (Clontech),
inserting an upstream SmaI site and deleting a nucleotide before the
BglII site. Then the fragment was digested with SmaI and BglII and
inserted in the HincII–BamHI sites of pEGFP, giving pEGFP2. An NcoI
fragment containing the eGFP ORFwas then inserted in the NcoI site of
pYX(770–875)eGFP and pYXeGFP(494–685), giving respectively pYX
(770–875)eGFP2 and pYXeGFP2(494–685). The fragment was also
inserted twice, giving pYX(770–875)eGFP3. As a control for eGFP
dimer localization, the NcoI eGFP fragment was also inserted in NcoI
digested pYXeGFP, giving pYXeGFP2.t lead the protein in the nucleus, spanning aa 353–875 and aa 876–1100. (A) Schematic
ated fragments of the putative regulatory N-terminal region of Cdc25. (B) W303-1a cells
pYX(353–875)eGFP (d), pYX(1–353)eGFP (e), pYX(770–875)eGFP3 (f) or pYX eGFP2
FP ﬂuorescence was photographed with a Nikon Eclipse E600 microscope.
Fig. 4. Localization of a set of Cdc25 deletion proteins as eGFP fusions conﬁrms that either aa 353–875 or aa 876–1100 regions are sufﬁcient to drive the protein to the nucleus. (A)
Schematic representation of the multicopy plasmids utilized to express different eGFP fusions, under CDC25 promoter, with the indicated deletion constructs of the Cdc25 protein, all
spanning the catalytic domain. Efﬁciency of each construct in complementation of the cdc25-5 ts defect is indicated. (B)W303-1a cells transformedwith YEp(904–1551)eGFP (a), YEp
(1147–1551)eGFP (b), YEp(Δ354–875)eGFP (c) or YEp(Δ876–1100)eGFP (d) were grown in the proper selective SD medium at 30 °C until exponential phase and then eGFP
ﬂuorescence was photographed with a Nikon Eclipse E600 microscope.
Table 1
Both the 354–876 aa and the 876–1100 aa regions contribute to the accumulation in the
nucleus of the Cdc25 protein, and their effect is counteracted by Tpk1 overexpression
W303-1A W303-1A [YEpTPK1]
YEpCDC25eGFP 33.6±0.8 23.9±1.0
Yep(Δ354–875)eGFP 23.9±1.4 24.5±1.2
Yep(Δ876–1100)eGFP 22.1±1.5 25.1±0.9
The percentage of ﬂuorescence in the nucleus was determined as described in Materials
andmethods for the indicated constructs expressed in the indicated strains (n=30, ±SD).
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using the deletion construct already described [19] and making it
recombine in yeast with the BglII digested YEp(904–1551)eGFP.
The YEplac195-CDC25(Δ876–1100) construct was obtained by
homologous recombination in yeast between the NcoI digested
pCDC25(LEU2)-2 plasmid and the 600 bp PCR fragment obtained
with RedAccuTaq enzyme (SIGMA) with the primers cdc25-9
(AAATCAGAATGTTTTACTATTGGAGATACTGGAGAATTTAAACCTTc-
catggTTTTTAACTTCAGATTATG) and cdc25-6 (GTCTGT ACGACTGCCGA-
TACCG) using the same plasmid as a template. The BamHI fragment
from the resulting YEplac195-CDC25(Δ876–1100) was recombined in
yeast with BglII-digested YEpCDC25eGFP, giving YEp(Δ876–1100)
eGFP. YEp(Δ354–875)eGFP plasmid was created by BglII fragment
deletion in YEpCDC25eGFP.
NES-GFP sequence was obtained from the pREV(1.4)NESGFP
plasmid [26] carrying the HIV Rev protein nuclear export sequence
(PVPLQLPPLERLTLDCNE) fused to the GFP protein, and subcloned as a
BamHI NotI fragment in pEGFP, giving pNES3-eGFP. The SphI NotI
fragment was then subcloned in SphI NotI cut pCAT-eGFP. The NES
sequence was then inserted between Cdc25 coding sequence and
eGFP ORF by homologous recombination between the BglII NotIfragment from this plasmid and YEpCDC25eGFP, giving YEpCDC25-
NES-eGFP. To generate the CDC25NES yeast strain, a construct was
prepared by inserting the NcoI (Klenow ﬁlled)–PvuII fragment from
pNES3-eGFP into the EcoRV site of pDH5 plasmid (from the National
Center for Research Resources at the NIH, University of Washington,
USA), containing the S. pombe his5+ gene, and NES was then fused to
CDC25 coding sequence by amplifying the NES and Sphis5+ sequence
by PCR, with the primers GAAGCTAGGTAAGAAAAAACCTCCTTCTAGGT-
TATTTCGAAGGTCGACTCTAGAGGATCCA and GCTAAGGTTCTTCTTGAT-
TAGCAAATTGTATAAACT-TTTACTGTTTAGCTTGCCTCGTCCCC.
Fig. 5. The fusion proteins spanning the central region of Cdc25 are highly insoluble.
Total proteins were extracted and fractionated by sequential centrifugation. The total
extract and supernatant equivalent to 6×107 cells, the triple for pellets at 5000 ×g and
16,000 ×g, were loaded on SDS-PAGE and immunoblotted withα-eGFP antibodies. Lane
1, total extract. Lane 2, pellet at 5000 ×g. Lane 3, pellet at 16,000 ×g. Lane 4, supernatant.
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The Cdc25 protein sequence was analyzed by the on-line
available tool PSORT II [27], for prediction of protein sorting signals
and localization sites in aminoacid sequences (http://psort.ims.u-
tokyo.ac.jp/).
2.4. Epiﬂuorescent microscopy
Cells were grown at 30 °C in the proper selective SD medium to
early exponential phase and observed with a Nikon Eclipse E600
microscope, ﬁtted with either a 40× or a 60× immersion objective and
a standard ﬂuorescein isothiocyanate ﬁlter set (Nikon, EX 450-490,
DM 505, BA 520) for GFP-ﬂuorescence, and a cy3 ﬁlter set for tdimer2
ﬂuorescence. Images were recorded digitally using a Nikon FDX-35
camera and processed using MetaMorph 6.3r1 (Molecular Devices,
Sunnyvale, CA) and Adobe Photoshop (Adobe Systems, Inc.).
Confocalmicroscopy imageswere collected using the Leica TCS SP2
confocal microscope equipped with an inverted Leica DMIRE2
microscope and a PL APO 63× oil immersion objective (numerical
aperture: 1.4). An average of 10 optical sections was acquired for every
single cell, and a representative single optical section or an average of
the most signiﬁcant ones is shown.
In vivo DAPI staining was performed by incubating exponentially
growing cells with 1.6 μg/ml DAPI for 2–3 h at 30 °C. Propidium iodide
(PI, Sigma Aldrich) staining was utilized to visualize DNA with the
confocal microscope. Brieﬂy, cells were ﬁxed in cold 70% (v/v) ethanol,
then washed with phosphate buffer saline (PBS, containing Na2HPO4/
NaH2PO4 10 mM, pH 7.2, 130 mM NaCl, 0.2 mM EDTA) three times,
treated with 2 mg/ml RNase in PBS for at least 2 h at 37 °C, washed
with PBS and incubated in propidium iodide 50 μM in Tris 50 mM
pH 7.7, MgCl2 15 mM for 30 min on ice.
Fluorescence measurements were performed by using MetaMorph
ﬂuorescence Integrated Intensity tools, and the percentage of nuclear
ﬂuorescence was calculated on at least thirty cells per strain as the
average ratio of the Integrated Intensity measured in the nucleus over
the Integrated Intensity of the whole cell.
For observation after hyperosmotic shock, hydrogen peroxide or
ethanol treatment, cells were grown at 30 °C in the proper selective SD
medium to early exponential phase. Some images were taken as time
zero, then a NaCl, hydrogen peroxide, or ethanol stock solution was
added to the culture, giving a ﬁnal concentration of 0.5 M NaCl, 2 mM
hydrogen peroxide or 10% ethanol respectively. At different times,
samples were taken and observed at the microscope, and images were
recorded of representative cells. For carbon and/or nitrogen starvation
treatments, cells exponentially growing in SD mediumwere collected
by ﬁltration and resuspended either in Mes/Tris 0.1 M pH 7, or in YNB
(Difco) 0.67 g/l or in YNB w/o ammonium sulphate (Difco) 0.17 g/l for
3 h. Rapamycin (Calbiochem) was added to cells growing in SD
medium to a ﬁnal concentration from 200 μg/l up to 10 mg/l.
2.5. Preparation of nuclear extracts
Nuclear extracts were prepared as described on the Hahn
Laboratory website (www.fhcrc.org/labs/hahn) with minor modi-
ﬁcations to scale-down the protocol. In order to evaluate the
contamination of the puriﬁed nuclei from the cellular membranes,
the following proteins were tested by immuno-blotting as mem-
brane markers: actin for proteins not associated to membranes, Gas1
for plasma membrane, ER and Golgi [28], Anp1 for Golgi apparatus
[29], Tom 40 for mitochondria [30], Pho8 for vacuolar membranes
[31] and Nop1 for nuclei [32]. Primary antibodies for Gas1 (kind gift
from M. Vai, University of Milano-Bicocca), Anp1 (kind gift from S.
Munro, MRC Lab of Molecular Biology, Cambridge, UK), Tom40 (kind
gift from T. Endo, Nagoya University, Japan) and Act1 (Sigma) were
raised in rabbits, antibodies against Pho8 (kind gift from J. Wind-erickx, K.U. Leuven, Belgium) and Nop1 (Encor Biotechnology) were
from mouse.
Nuclear extracts were prepared from OL568-1C strain, W303-1a
strain carrying YEpCDC25eGFP and CDC25NES strain, giving similar
results as far as membrane markers or Ras2 detection in nuclear
extracts is concerned.
2.6. cdc25-5 defect complementation assay
The OL97-1-11B strain (Mata leu2 ura3 his3 his7 cdc25-5), which
has a temperature sensitive growth defect, was transformed with the
plasmids driving the expression of different GFP fusion proteins and
the rescue of growth at the restrictive temperature of 37 °C was
evaluated as the percentage of colonies growing at restrictive
temperature with respect to the colonies growing at permissive
temperature.
2.7. Solubility assay
Cells expressing the different fusion proteins were grown in the
proper selective SD media at 30 °C to the density of 0.5–0.8 OD600,
then collected by centrifugation and frozen. Extracts were prepared by
breaking cells with glass beads in a FastPrep (Savant) in HB buffer
(25 mM MOPS pH 7.2, 15 mM MgCl2, 15 mM EGTA, 1 mM PMSF,
10 mg/ml pepstatin A, Complete EDTA-free Protease Inhibitor Mixture
from Roche Applied Science). Fractionation was performed by
sequential centrifugation at 5000 ×g at 4 °C, which gave the ﬁrst
pellet (P5), and then at 16,000 ×g, which gave the second pellet (P16)
and the supernatant (S). The extracts, P5, P16 and S were loaded on
SDS-PAGE, transferred to nitrocellulose and decorated with eGFP
directed BD Living Colors A.v. Antibodies (BD Biosciences Clontech)
and α-rabbit antibodies conjugated to peroxidase (Jackson Immuno-
research). The extract equivalent to 6×107 cells was loaded for total
extract and S, a triple amount was loaded for P5 and P16.
2.8. Anti-Nop1 immunoﬂuorescence
Cells harbouring pYX212-CDC25(353–1100)-eGFP were grown in
SD-ura medium at 30 °C until early exponential phase, then the
culture was buffered with a stock phosphate buffer, leading to a ﬁnal
concentration of K2HPO4/KH2PO4 100 mM, pH 6.5, and ﬁxed with 3.7%
formaldehyde for 30 min at room temperature. Then, cells were
recovered by ﬁltration and ﬁxed again for an additional 1 h at room
temperature in 100 mM phosphate buffer pH 6.5, 3.7% formaldehyde.
Cells were collected by ﬁltration and washed three times with
phosphate buffer, then once with digestion buffer (1.2 M sorbitol,
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Fig. 6. Cdc251–1551 aa and 353–1100 aa eGFP fusions localize inside the nucleus: the introduction of a heterologous nuclear export signal can exclude the protein from the nucleus. In
detail, Cdc25 localize to the non-nucleolar region of the nucleus. Unless differently indicated, photographs were obtained with Nikon Eclipse microscope as described in Materials
and methods section. (A) Co-localization of eGFP ﬂuorescence and DNA (DAPI stained) inW303-1a cells transformed with YEpCDC25eGFP (a), pYX(353–1100)eGFP (b) or YEpCDC25-
NES-eGFP (c). (B) Co-localization of eGFP ﬂuorescence and Nup49, a protein of the nuclear envelope, as a tdimer2 ﬂuorescent protein fusion, in KT98 cells transformed with
YEpCDC25eGFP (a), pYX(353–1100)eGFP (b) or YEpCDC25-NES-eGFP (c). (C) Single optical section obtained by confocal microscopy analysis of W303-1a cells transformed with pYX
(353–1100)eGFP and stained with propidium iodide to visualize DNA. (D) Co-localization of eGFP ﬂuorescence and the nucleolar protein Nop1, immuno-detected as described in
Materials and methods, in W303-1a cells transformed with pYX(353–1100)eGFP. DNA was stained with DAPI.
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with 0.25 g/l zymolyase 20 T (ICN), 200 μM β-mercaptoethanol and
incubated for up to 1 h at 37 °C. In the meanwhile, a multiwell slide
(ICN) was coated with poly-L-lysine (SIGMA) 1 mg/ml for 10 s, then
washed three times with water and let dry. After digestion of the cell
wall, cells were collected at 2000 rpm for 10 min in a microfuge,
resuspended in digestion buffer and placed on the slide for 10 s;
unattached cells were aspirated off and the slides were immersed in
−20 °C pre-cooledmethanol for 6min and then in cold acetone for 30 s
to permeabilize cells.
To immunodecorate cells, the wells were washed 3 times with
phosphate buffer saline (PBS, containing Na2HPO4/NaH2PO4 10 mM,
pH 7.2, 130 mM NaCl, 0.2 mM EDTA), incubated 5 min with PBS and
0.1% Triton X-100 to reduce autoﬂuorescence, then washed again 3
timeswith PBS. Stainingwith antibodyα-Nop1 (EnCor Biotechnology)
1:100 in PBS 1% BSA was conducted for 1 h in a humid chamber, then
wells were washed 10-times with PBS 0.1% BSA and covered with
secondary antibody (Jackson Immunoresearch, goat α-mouse-Cy3
conjugated, 1:400 in PBS 1% BSA), incubated for 1 h at room
temperature in a dark humid chamber, then 10-times washed before
incubation for 10 min with DAPI 200 mg/l. After 5 washes with PBS
0.1% BSA, slides were mounted with 75% glycerol in PBS.
3. Results
3.1. Mild overexpression of Cdc25 full protein eGFP fusion results in its
import into the nucleus
Previous studies on Cdc25 localization revealed that the protein
co-segregates with a crude membrane fraction after centrifugation
[8,17,20,21]. However, more accurate cell fractionation experiments
have never been reported that could indicate the cellular compart-
ment where Cdc25 is located. An immunolocalization experiment of
the overproduced catalytic domain or the full-length protein [21]
showed a labelling in patches near the cell periphery, distinct from
actin patches.
With the aim of investigating Cdc25 localization in physiological
conditions, a fusion was made between the Cdc25 protein and the
green ﬂuorescent protein (eGFP). As a single copy integrated in the
CDC25 locus, this fusion was expressed at a very low level, as it is
the case for the wild type protein, mainly due to its short half-life [12].
The ﬂuorescent signal from the fusion protein was very low, giving a
diffuse but not uniform labelling of the cells (Fig. 1A, subpanel a),
possibly suggesting an association with the internal membrane
system, but in no case labelling of the cell surface was observed.In order to increase the amount of proteinwithin the cell, the Cdc25
(1–1551)eGFP fusion was also inserted in a multicopy plasmid, under
the control of the CDC25 promoter. This kind of overexpression did not
give any phenotypical defect in the W303-1a strain (heat shock
sensitivity, iodine staining, growth on different carbon sources, cell
size, percentage of budded cellswere tested), but raised the level of the
protein enough to be faintly detectable on anti-GFPWestern blot (data
not shown): this was enough to produce a remarkable effect on the
ﬂuorescence distribution inside the cells. Instead of accumulating in
cell membrane compartments, as suggested by solubility assays in
literature, the fusion protein showed an evident ﬂuorescence pattern
that suggested an accumulation in the nucleus (Fig. 1A, subpanel b).
Since the C-terminal 38 residues were removed in the Cdc25
(1–1551)eGFP fusion and the presence of the eGFP protein at the
C-terminal could modify the normal localization of the protein,
another fusion was made with eGFP in the N-terminal position,
immediately before the ﬁrst residue of the Cdc25 protein, and
expressed under the control of CDC25 promoter on an episomic
plasmid. This fusion protein showed exactly the same pattern as the
C-terminal eGFP fusion (Fig. 1A, subpanel c), showing that GFP tag was
not affecting Cdc25 localization.
No correlation between bud morphology and Cdc25 distribution
was seen, suggesting that localization was not regulated by the cell
cycle, nor the localization was different during growth on carbon
sources different than glucose, such as galactose or not fermentable
carbon sources as glycerol.
In order to better observe the presence of the full protein in
membrane compartments, the strain expressing the Cdc25(1–1551)
eGFP fusion was observed with a confocal microscope. The ﬂuores-
cencewas revealed not only in the central region of the cell, but also in
the cytosol, with a pattern suggesting association to the internal
membranes (Fig. 1B).
3.2. Cdc25 protein co-puriﬁes with nuclei even if not overexpressed
The hypothesis of a nuclear localization was further investigated
through a puriﬁcation of yeast nuclei as described in theMaterials and
methods section. The nuclear protein Nop1 was used as a nuclear
marker, and it was enriched several times (from 3 to 6 times) in the
nuclear extract, as expected. Cdc25 was also enriched in the nuclear
extract, to a similar extent than Nop1, in the strain expressing
Cdc25eGFP fusion on a multicopy plasmid (Fig. 2).
The eGFP fusions would have allowed to rapidly test the Cdc25
protein fragments required for nuclear localization but, in order to
obtain a detectable signal, overexpression was required. This leads to
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protein level the localization could be different. A Cdc25 version was
used with a N-terminal triple-HA tag inserted in the CDC25 locus,
which allows a good detection of the protein by western blot [23] at
physiological levels of expression. Alsowhen Cdc25 (triple-HA tagged)
was not overexpressed (Fig. 2), Cdc25 was enriched in the nuclear
extract like Nop1 was, indicating a signiﬁcant presence of the Cdc25
protein in the nuclei also at physiological levels of expression. Several
markers for intracellular proteins were tested in the nuclear extract,
since residual internal membranes could still be present as a
contamination in the nuclei preparation and a correct evaluation of
the inﬂuence of these contaminations is necessary. All the markers
used for internal membranes were present in traces in the nuclear
fraction: in fact the plasma membrane, ER, Golgi, mitochondria or
vacuolar membrane markers were almost lost in the nuclei fraction
when compared to the total extract, giving similar results both in the
OL568-1C strain (Fig. 2) or in the W303-1a strain carrying YEpCD-
C25eGFP (not shown). Differently from Cdc25, Ras2 was not enriched
at all in the nuclear extract, showing a pattern that is comparable to
the membrane markers.
3.3. Nuclear localization relies on the central region (aa 353–1100) of
Cdc25 protein
Since neither the fusionwith eGFP nor the overexpression seemed
to affect the localization of Cdc25 protein, several constructs were
produced to overexpress the whole N-terminal region (residues
1–1100) or different fragments of this region (Fig. 3A) as eGFP fusions
in a multicopy plasmid under a constitutive promoter (TPI1), in order
to identify the regions of the protein responsible for the nuclear
localization. These experiments revealed that either the presence of
the aa 353–875 or of the aa 876–1100 regions was sufﬁcient to lead the
fusion protein into the nucleus (Fig. 3B), but with some additive effects
in the fusion protein spanning aa 353–1100.
The on-line available tool PSORT II [27] was used for prediction of
sorting signals and localization sites in Cdc25 sequence. This analysis
revealed four putative nuclear localization signals situated at positions
547, 806, 1408 and 1580, giving a prediction of nuclear localization
with a 78.3% conﬁdence.
The ﬁrst two predicted NLSs (situated at positions 547, 806) are
situated in the 353–875 region, that shows nuclear localization, but no
putative NLS could be identiﬁed in the 876–1100 region, which is
equally imported into the nucleus. The two NLSs were separately
fused with eGFP in the pYX(770–875)eGFP3 and in the pYXeGFP2
(494–685) constructs (Fig. 3A), where eGFP protein was used in more
than one copy to obtain proteins big enough not to be efﬁciently
imported into the nucleus without a speciﬁc nuclear import signal.
Both of these fusion proteins were able to enter the nucleus, but only
the pYX(770–875)eGFP3was observed to accumulate into the nucleus
more than in the cytosol, even if none of them accumulated in the
nuclear compartment at the same extent as the construct spanning
both of them (Fig. 3B, subpanels f and g).
To conﬁrm the role of these regions in the localization of the full-
length protein into the nucleus, some deletion constructs were
produced, still spanning the catalytical domain and thereby retaining
catalytical activity, starting from the YEpCDC25eGFP multicopy
plasmid expressing Cdc25(1–1551)eGFP fusion under the CDC25
promoter control (Fig. 4A). Only the deletion of the entire N-terminal
region (1–1146) could abolish the nuclear accumulation of the eGFP
fusion protein (Fig. 4B), suggesting that the more C-terminal NLSs
identiﬁed by PSORT II analysis are actually not functional. The deletionFig. 7. Cdc25 can physiologically be exported to the cytoplasm after hyperosmotic shock. The
shock. Photographswere obtainedwith Nikon Eclipsemicroscope as described inMaterials an
eGFP (c and d) were photographed before (a and c) and 10min after (b and d) being challenge
before and 10 min after hyperosmotic shock and co-localization is shown with Nup49–tdimof the single regions, either 354–875 or 876–1100, caused a decrease
of the ﬂuorescence ratio of the nucleus compared to the cytoplasm.
Western blot analysis revealed that these two constructs were
expressed at a level comparable to the Cdc25(1–1551)eGFP, so the
deletion of either of the two regions does not affect the production or
stability of the protein. Total ﬂuorescence intensity of the whole cell
and of the nuclear compartment were measured as described in
Materials and methods, and the average proportion of ﬂuorescence in
the nucleus was calculated (Table 1): for cells carrying YEpCDC25eGFP,
33.6±0.9% of the ﬂuorescence was nuclear, while for YEp(Δ354–875)
eGFP or YEp(Δ876–1100) the nuclear ﬂuorescence dropped to
23.9±1.4% and 22.1±1.5%. This suggests an additive effect of the two
regions, 354–875 and 876–1100, in determining either the rate of
import or the retention of the fusion proteins in the nucleus.
In order to assess the functionality of the deletion constructs a
complementation assay was performed utilizing a cdc25-5 ts strain,
which has a temperature sensitive growth defect. As shown in Fig. 4A,
all the fusions spanning the catalytic domain (which is essential for
viability) were able to rescue the growth arrest at restrictive
temperature, with minor differences in the efﬁciency likely due to
differences in the expression levels (as could be evaluated from the
intensity of the ﬂuorescence observed in cells carrying the different
constructs) or to the lower activity of the shortest catalytical domain
(1147–1551 aa) [19].
3.4. eGFP fusion proteins spanning either catalytical domain or the
central region of Cdc25 are insoluble
As already mentioned, Cdc25 protein is poorly soluble and after
centrifugation always segregates in the pellet fractions [4,8,17,20]. This
was often taken as a demonstration that the protein should reside in
membranes, notably at the plasma membrane level. More recently,
Ras2 protein was shown to accumulate more on internal membranes
than on the plasma membrane [34] unless it was overexpressed, and
the same could be true for Cdc25 RasGEF. Consistently with literature
reported data, in a fractionation assay by differential centrifugation all
the fusion proteins spanning the catalytical C-terminal domain
resulted highly insoluble, and were associated to the pellet obtained
after centrifugation at 5000 ×g (P5) or 16,000 ×g (P16) (data not
shown). This indicates that the co-migration in the insoluble fraction
in a differential centrifugation assay is not enough to assess the
membrane association of these proteins, and that these proteins could
associate with some insoluble component inside the nucleus.
On the contrary, the 411 aa N-terminal portion was reported to be
at least partially soluble [21], but nothing was known about the
central region of the protein. Cells expressing the fusion proteins
spanning either the 354–875 aa, the 876–1100 aa, or 354–1100 aa
regions were fractionated by centrifugation and resulted completely
insoluble. In fact, as it is shown in Fig. 5, they were found in the pellet
obtained at 5000 ×g, suggesting that they contribute to the very low
solubility of the full length protein. This also suggests that nuclear
accumulation of the 354–875 aa, the 876–1100 aa, or 354–1100 aa
spanning proteins does not imply that these constructs are soluble:
they could associate with the nuclear envelope or with insoluble
components of the nuclear matrix.
3.5. Cdc25 accumulates in the non-nucleolar compartment of
the nucleus
Nuclear localization was assayed by ﬂuorescence microscopy by
colocalization with DNA (DAPI staining) (Fig. 6A). Actually, the eGFP353–1100 aa region is sufﬁcient to observe the nuclear export induced by hyperosmotic
dmethods section. (A) Cells transformedwith YEpCDC25eGFP (a and b) or pYX(1–1100)
dwith a hyperosmotic shock. (B) Cells carrying pYX(353–1100)eGFPwere photographed
er2 ﬂuorescence to visualize the nuclear boundary.
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Fig. 8. Cdc25NES protein is excluded from the nuclei. Nuclei were prepared from
exponentially growing cells of CDC25NES strain as described in Materials and methods.
Total extract (30 μg of proteins) and the corresponding amount of nuclei fraction (1/6th
of the proteins loaded for total extract) were loaded on SDS-PAGE and the indicated
proteins were visualized by western blot.
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but was nonetheless inside the nuclear compartment, as could be
deﬁnitively demonstrated by co-localization with the nuclear enve-
lope protein Nup49 (Fig. 6B) [35]. The pattern observed excluded that
the Cdc25 fusion protein could be uniquely associated with the
nuclear envelope, since the ﬂuorescence was found both inside the
nucleus and in its periphery. Furthermore, a construct was obtained by
inserting a very strong nuclear export signal (NES), the HIV virus Rev
protein NES [26] between Cdc25 portion and GFP tag. In fact,
mammalian NES sequences have already been successfully used in
yeast [33]. The insertion of Rev NES sequence completely excluded the
Cdc25NESeGFP protein from the nucleus (Fig. 6A and B, subpanels c),
reinforcing the hypothesis that the protein is localized inside the
nucleus. A further more detailed analysis was performed on the more
stably expressed fragment, spanning aa 353–1100, by confocal
microscopy. In fact, this analysis conﬁrmed that the eGFP ﬂuorescence
was adjacent to the DNA, as visualized by propidium iodide staining
(Fig. 6C). In yeast, nucleoli often assume a ﬂatten shape, in the
peripheral nucleus [32], which could have explained the observed
morphology. However, the immunoﬂuorescence against the nucleolar
protein Nop1 [36] revealed that the Cdc25(353–1100)eGFP fusion
localizes in the non-nucleolar compartment of the nucleus (Fig. 6D).
3.6. Cdc25 nuclear localization can be affected by
physiological regulations
It was reported in literature that, when yeast cells are exposed to
environmental shocks, many nuclear proteins rapidly relocate to the
cytoplasm [37,38]. In order to investigate if the nuclear localization
observed for some Cdc25 eGFP fusions was physiologically regulated
and could respond to relocalization signals, their behaviour was
observed either after exposure to ethanol, hydrogen peroxide or after
hyperosmotic shock.
Ethanol and hydrogen peroxide exposure are stress treatments
that can inhibit nuclear import [37], but these treatments didn't affect
the distribution of any of the fusion proteins (not shown) suggesting a
more complex control not only on nuclear import, but also on nuclear
retention and export. Conversely, the 1–1551 aa fusionmigrated to the
nuclear envelope and then was exported from the nucleus within
10 min after the hyperosmotic shock (Fig. 7A, subpanels a and b),
relocating to the nucleus within 40 min after the shock (not shown).
Also the N-terminal region (1–1100 aa) fusion was regulated in a
similar way (Fig. 7A, subpanels c and d), as well as the proteinFig. 9. Cdc25 exclusion from the nucleus impairs growth on non fermentable carbon sourc
transferred to YP plates supplemented with 3% glycerol and incubated at the indicated temspanning residues 353–875, or 876–1100 (data not shown). A more
complex pattern was observed for Cdc25(353–1100)eGFP, probably
due to the high level of protein accumulated in the nucleus. This
protein was not completely exported from the nucleus, and often
stuck into the nuclear envelope, as revealed by comparison with a
nuclear envelope protein, Nup49 (Fig. 7B).
No differences in nuclear localization were observed in cells in
different phases of the cell cycle, neither starvation for glucose or
nitrogen sources nor rapamycin treatment inﬂuenced the nuclear
localization of Cdc25(1–1551)eGFP fusion. Only PKA activity could
partially counteract Cdc25 nuclear import: the overexpression of Tpk1,
one of the catalytic subunits of PKA, could reduce the percentage of
nuclear ﬂuorescence in the strain expressing the Cdc25eGFP protein at
the same extent as the 354–875 aa or 876–1100 aa deletions (Table 1).
These observations indicate that an active transport into and out of
the nucleus can regulate Cdc25 protein distribution between nucleus
and cytoplasm, suggesting that the protein can shuttle from the
nucleus to the cytoplasm and vice versa.
The expression of the Cdc25NESeGFP protein didn't cause any
evident phenotype in the cells: growth, percentage of budded cells,
cell size, heat shock resistance were similar to the wild-type strain,
and no defect in the utilization of galactose could be observed. This
could be explained by the presence of the wild-type allele in the
strain, that can still operate in the nucleus, although the wild-type
protein is also efﬁciently exported from the nucleus in this strain,
probably due to association with the NES containing Cdc25 version
(data not shown).
In order to clarify if Cdc25 could have any function in the nuclei, a
mutant was created where the Cdc25 protein contained the HIV Rev
protein NES sequence. This sequence was able to efﬁciently exclude
the Cdc25NES protein from the nuclei (Fig. 8), but the mutant strain
(CDC25NES) was viable and didn't show any growth defect on glucose,
nor it was more or less sensitive than the control strain to heat shock,
osmotic stress or oxidative stress (data not shown). Interestingly, the
CDC25NES strain cannot hardly grow on glycerol (Fig. 9) or ethanol
(not shown), suggesting a role for Cdc25 protein in the nucleus either
in derepression from glucose or during growth on non-fermentable
carbon sources.
4. Discussion
The S. cerevisiae RasGEF Cdc25 plays its essential function on
membranes, where its main interacting proteins, Ras and the
adenylate cyclase, seem to localize. Actually, Ras2 proteinwas recently
found to mainly localize in internal membranes, and not to
accumulate in the plasma membrane [34,39], as it was previously
suggested [40,41].
Anyway, the nuclear localization of the Cdc25 eGFP fusions is quite
surprising, but it is likely to be speciﬁc and physiological, since it can
respond to relocation signals such as hyperosmotic shock-induced
nuclear export. This localization seems to rely on sequences present in
the central region of the protein, from aa 353 to aa 1100, which is a
largely uncharacterized region of this protein, and no known pattern
or proﬁle could be found by online available tools for pattern andes. Cells of OL568-1C strain (CDC25) and CDC25NES strain, growing on YPD plate, were
perature.
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mics server of the Swiss Institute of Bioinformatics (SIB) (MotifScan,
InterProScan, ScanProsite and other tools were used). This region is
not conserved in RasGEFs of other organisms, except for S. cerevisiae
Sdc25 and other Cdc25 homologs from other yeasts, like CaCdc25 of
Candida albicans (accession number S30356), or SkCdc25 of Saccha-
romyces kluyveri (accession number Q02342). An interfering activity of
this central region on Cdc25-dependent phenotypes was reported
both for the 347–875 aa [18] and the 876–1100 aa [19] regions, but the
mechanism of this interference is not known. Either one of the two
central regions can be deleted without affecting the rescue of cdc25-5
temperature sensitive defect; consistently, it was previously reported
that a 353–875 residues deletion doesn't inhibit the efﬁciency of basal
or inducible adenylate cyclase activity [14].
The two putative nuclear localization signals situated at positions
547 and 806 (NLSI and NLSII) are able to direct into the nucleus the
fragments containing both or either one of them (Fig. 3). The most
efﬁcient is the NLSII, a bipartite NLS, also present in Sdc25. Its
sequence is KRKKKYPLTVDTLNTMKKKSS: the two ﬁnal serine residues
were previously considered as PKA phosphorylation sites [14], and are
highly conserved in other yeasts Cdc25 homologs, as well as the
hydrophobic core of the motif and the acidic residue in the middle.
Cdc25 was shown to be hyper-phosphorylated in response to glucose,
resulting in reduced accessibility to Ras [17]: the serine residues near
the NLSII could be targets of PKA regulation on Cdc25 activity or
localization.
However, the nuclear localization of Cdc25 is not only due to
nuclear import: sensitivity to hyperosmotic shock suggests a more
complex regulation on nuclear retention of the protein, since
hyperosmotic shock was reported not to affect nuclear import but to
cause an immediate dissociation of most proteins from chromatin,
rapidly recovered in 5–10 min by activation of the High Osmolarity
Glycerol (HOG) pathway [42].
The unexpected nuclear localization of Cdc25 protein could
indicate that the protein function can be regulated, apart from the
rapid turn-over of the protein, also by relocalization from the cytosol
to the nucleus. Nuclear import could subtract Cdc25 from its
membrane-attached partners (i.e. Ras1,2 and adenylate cyclase), or
have an effect on the degradation rate of the protein. Actually, no
difference was observed in PKA activity related phenotypes or in the
expression level for the Cdc25eGFP and the Cdc25NESeGFP, which
would exclude any effect of down-regulation in Cdc25 activity by
being sequestered in the nucleus or more rapidly degraded.
Nuclear localization could also be indicative of a speciﬁc nuclear
function for Cdc25. In fact, it was previously reported that Cdc25
overexpression was involved in speciﬁc transcriptional effects. This
could suggest a direct or indirect involvement of Cdc25 in the
regulation of transcription, and a requirement of the nuclear
localization determinants for the assessment of these functions. It
was previously suggested that Cdc25 can be phosphorylated not only
by PKA subunits [43], but also by Kss1 and Fus3 MAPK kinases [44]:
Cdc25 would be a likely control point for MAPKs cross-regulation on
Ras signaling, and this could happen in the nucleus, where the active
MAPKs seem to reside [45].
Otherwise, we suggest that Cdc25 could have additional, not
essential, Ras-independent functions in the nucleus. In fact, the
CDC25NES strain, where Cdc25 is prevented from accumulating in the
nucleus, cannot hardly grow on non fermentable carbon sources.
Consistently, it was previously suggested that Cdc25 could be involved
in peculiar transcriptional effects that are not PKA dependent, such as
glucose derepression [46], and that Cdc25 is required for regulation of
galactose-induced genes [5,47]; furthermore, besides several interac-
tions of Cdc25 with proteins with a nuclear localization or a nuclear
function had independently been reported, such as Clb3 [48], Nﬁ1
[49], Swc4 [50], Cdc25 was also found in complexes containing
nuclear proteins such as Enp1, Glc7 and Fpr3 [51]. Further studies willfocus on determining if gene transcription is affected by Cdc25
presence in the nucleus.
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